Advertisement

Topics

LALLEMAND Inc Company Profile

23:04 EST 12th December 2018 | BioPortfolio

Lallemand Inc. is a privately held Canadian company specializing in the development, production, and marketing of yeasts and bacteria. The company has three major divisions: North American Bakers Yeast and Ingredients (based in Chicago, USA), European Yeast (based in Vienna, Austria) and Specialty (based in Toulouse, France). Administrative offices for the parent company are in Montreal, Quebec, Canada.
North American Bakers Yeast and Ingredients Division operates through the subsidiaries Lallemand Distribution in Canada, American Yeast Sales in the U.S., and Galliapan in Mexico. It produces fresh, cream, and instant bakers yeast along with dough conditioners and baking powders. These products, along with a broad range of other baking ingredients, are marketed through its own sales and distribution organization.

Location

151 Skyway Avenue
Rexdale
Ontario
M9W 4Z5
Canada

Contact

Phone: (514) 522 - 2133
Fax: (514) 522 - 2884
Email: info@lallemand.com


News Articles [5 Associated News Articles listed on BioPortfolio]

Global and Asia Fermentation Ingredients Market Status and Future Forecast 20132023 [Report Updated: 20082018] Prices from USD $3000

SummaryKey Content of Chapters Including and can be customizedPart 1:Market Overview, Development, and Segment by Process, Type, Application RegionPart 2:Global Market by company, Process, Type, Appl...

Europe Silage Inoculant Market Growth, Trends, and Forecast 2018 2023 [Report Updated: 08022018] Prices from USD $3850

European silage inoculants market is expected to cross USD 145 million by 2023 with an estimated CAGR of 5%. European countries are leading the market with 40% of the global share. Spain, UK, and Fran...

Europe Silage Inoculant Market Growth, Trends, and Forecast 2018 2023 [Report Updated: 08022018] Prices from USD $1922

European silage inoculants market is expected to cross USD 145 million by 2023 with an estimated CAGR of 5%. European countries are leading the market with 40% of the global share. Spain, UK, and Fran...

Global Beneficial Bacteria Market Status and Outlook 20182025 [Report Updated: 18082018] Prices from USD $4000

Report SnapshotKey Content of Chapters Including and can be customized, report is a semifinished version, and it takes 4872 hours to upgradePart 1:Terminology Definition, Industry Chain,Industry Dynam...

Global Bread Improver Market Status and Outlook 20182025 [Report Updated: 16082018] Prices from USD $4000

Report SnapshotKey Content of Chapters Including and can be customized, report is a semifinished version, and it takes 4872 hours to upgradePart 1:Terminology Definition, Industry Chain,Industry Dynam...

Drugs and Medications [0 Results]

None

PubMed Articles [0 Results]

None

Clinical Trials [1 Associated Clinical Trials listed on BioPortfolio]

Effects of Probiotics on Symptoms of Depression

Preclinical and clinical studies have shown that consuming probiotics can improve mood, anxiety, and cognition, as well as alter brain activity in both rodents and healthy humans. Data fro...

Companies [1 Associated Companies listed on BioPortfolio]

LALLEMAND Inc

Lallemand Inc. is a privately held Canadian company specializing in the development, production, and marketing of yeasts and bacteria. The company has three major divisions: North American Bakers Yeas...

More Information about "LALLEMAND Inc" on BioPortfolio

We have published hundreds of LALLEMAND Inc news stories on BioPortfolio along with dozens of LALLEMAND Inc Clinical Trials and PubMed Articles about LALLEMAND Inc for you to read. In addition to the medical data, news and clinical trials, BioPortfolio also has a large collection of LALLEMAND Inc Companies in our database. You can also find out about relevant LALLEMAND Inc Drugs and Medications on this site too.

Advertisement
Quick Search
Advertisement
Advertisement

 

Relevant Topic

The Top 100 Pharmaceutical Companies
Top 10 biotech and pharmaceutical companies worldwide based on market value in 2015 2015 ranking of the global top 10 biotech and pharmaceutical companies based on revenue (in billion U.S. dollars) Johnson & Johnson, U.S. 74...


Corporate Database Quicklinks



Searches Linking to this Company Record